THE EFFICACY OF INTRAMUSCULAR OZONE THERAPY IN PAIN MANAGEMENT OF MYOFASCIAL PAIN SYNDROME WITH TRIGGER POINTS: PILOT STUDY

Status

Unknown

Phases

Phase 4

Study type

Interventional

Source

TCTR

Registry ID

TCTR20240326005

Enrollment

Registered

2024-03-26

Start date

2024-03-16

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myofascial Pan Syndrome with Trigger Points Myofascial pain syndrome, Trigger points

Interventions

1. Prepare ozone by Hyper Medozon Comfort Machine with ozone concentrate 20 micrograms/ml in syringe 10 ml 2. Clean on trigger points with 70% alcohol 3. Inject ozone into muscle with 27g needle in 1

Experimental Other

Intramuscular ozone therapy

Eligibility

Sex/Gender

All

Age

25 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1.Myofascial pain syndrome with trigger points on neck and shoulders area. 2.Pain score is equal or over than 4. Graded by visual analogue scale.

Exclusion criteria

Exclusion criteria: 1.contraindication of ozone therapy such as G-6-PD deficiency, uncontrolled hyperthyroid, uncontrolled cardiovascular disease, etc. 2.can not attend all 3 session of treatment and can not follow up all protocol 3.take medicine such as NSAIDs, Muscle relaxant within 2 weeks 4.get other treatments such as massage, physiotherapy, acupuncture, etc. within 4 weeks 5.take supplements in blood thinning agent group or anti-inflammation group

Design outcomes

Primary

Measure	Time frame
Pain score 1 week after end of intervention Visual Analogue scale	—

Secondary

Measure	Time frame
N/A N/A N/A	—

Countries

Thailand

Contacts

Public ContactWariya Charoenrakpakdee

Department of Anti-Aging and Regenerative Science College of Integrative Medicine

65130124@dpu.ac.th0988696965

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026